Results for tag: "Hypoplastic Left Heart Syndrome"

Hypoplastic Left Heart Syndrome (HLHS) is a rare congenital heart defect in which the left side of the heart is underdeveloped. This condition affects the normal flow of blood through the heart, leading to a decrease in oxygen-rich blood to the body. Symptoms of HLHS include shortness of breath, fatigue, and poor feeding. Treatment for HLHS typically involves a series of surgeries, including the Norwood procedure, the Glenn procedure, and the Fontan procedure. The HLHS market is a niche segment of the larger cardiology market. It is composed of medical device companies, pharmaceutical companies, and healthcare providers. Medical device companies develop and manufacture products such as heart valves, catheters, and stents that are used in the treatment of HLHS. Pharmaceutical companies develop and market drugs that are used to treat the symptoms of HLHS. Healthcare providers, such as hospitals and clinics, provide the necessary medical care for patients with HLHS. Some companies in the HLHS market include Edwards Lifesciences, Medtronic, Boston Scientific, Abbott, and Johnson & Johnson. Show Less Read more